Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.

Park JG, Xu X, Cho S, Lee AH.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1772-81. doi: 10.1161/ATVBAHA.116.307790. Epub 2016 Jul 14.

2.

Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.

Mahley RW.

Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1305-15. doi: 10.1161/ATVBAHA.116.307023. Epub 2016 May 12. Review.

3.

Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism.

Martins da Fonseca CS, Pimenta Filho AA, dos Santos BS, da Silva CA, Domingues AL, Owen JS, Lima VL.

PLoS One. 2014 Jul 22;9(7):e101964. doi: 10.1371/journal.pone.0101964. eCollection 2014.

4.

Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.

Leman LJ, Maryanoff BE, Ghadiri MR.

J Med Chem. 2014 Mar 27;57(6):2169-96. doi: 10.1021/jm4005847. Epub 2013 Oct 29. Review.

5.

Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity.

Subbaiah PV, Jiang XC, Belikova NA, Aizezi B, Huang ZH, Reardon CA.

Biochim Biophys Acta. 2012 Jun;1821(6):908-13. doi: 10.1016/j.bbalip.2012.02.007. Epub 2012 Feb 18.

6.

Domains of apoE4 required for the biogenesis of apoE-containing HDL.

Vezeridis AM, Chroni A, Zannis VI.

Ann Med. 2011 Jun;43(4):302-11. doi: 10.3109/07853890.2010.549143.

7.

Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.

Zhu Y, Bellosta S, Langer C, Bernini F, Pitas RE, Mahley RW, Assmann G, von Eckardstein A.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7585-90.

8.

Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.

Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ, Reue K.

J Clin Invest. 1997 Apr 15;99(8):1906-16.

9.

Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.

Rader DJ, Schäfer J, Lohse P, Verges B, Kindt M, Zech LA, Steinmetz A, Brewer HB Jr.

J Clin Invest. 1993 Aug;92(2):1009-17.

10.

Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator.

Barter PJ, Rajaram OV, Chang LB, Rye KA, Gambert P, Lagrost L, Ehnholm C, Fidge NH.

Biochem J. 1988 Aug 15;254(1):179-84.

Supplemental Content

Support Center